Temporary cerebral ischemia (15 min) pro duced by "four-vessel occlusion" in the rat causes neu rological disorders, changes in behavior (locomotor hy peractivity), and neuronal damage in the neocortex, stri atum, and especially the CAl zone of the hippocampus. We have studied the effects of two calcium overload blockers, flunarizine (50 mg/kg p.o. twice a day) and cin narizine (100 mg/kg p.o. twice a day), on these alter ations. Cinnarizine markedly improved the functional ab normalities of ischemia but had little or no effect upon the neuronal damage. In contrast, flunarizine provided far greater neuronal protection but with less obvious effects
Cerebral ischemia induces both immediate and delayed neuronal death according to the selective vulnerability of the neurons, which in turn depends upon the inherent functional and metabolic charac teristics of the nerve cells and the blood supply to that particular brain area (Farder, 1981; Simon et al. , 1984; Siesj6, 1988) . Calcium overload is thought to be one of the main factors inducing neuronal death (Simon et al., 1984; Siesj6, 1988; Deshpande and Siesj6, 1987) and several studies have shown a close temporal relationship between the accumula tion of calcium and the progression to ischemic cell death in a number of experimental animal models (Hossmann et al. , 1983; Dienel, 1984) . Although the demonstration of increased cellular levels of cal cium ions in ischemic tissues does not, of itself, upon behavioral parameters. However, there was evi dence of sedation 2 h after treating animals with this dose of flunarizine that might have masked any positive effect of the drug on behavior. We conclude that under the present experimental conditions, there is no correlation between the early and late behavioral changes observed following a temporary cerebral ischemic episode and the histological damage observed in certain vulnerable neu rons, particularly in the hippocampus, 72 h after the in sult. Key Words: Four-vessel occlusion model-Cerebral ischemia-Behavioral changes-Histology-Cinnari zine-Flunarizine.
prove that ischemic cell injury is mediated by an increase in cytosolic free calcium ions, a primary and specific early uptake of calcium after ischemia has recently been reported to occur in the rat hip pocampus (Benveniste and Diemer, 1988) . Intracel lular calcium accumulation elicits many effects that could contribute to neuronal degeneration including cytoskeleton modifications, activation of phospho lipases, nucleases, and proteases, and free radical production.
Calcium antagonists have been used with some success in myocardial ischemia and their potential benefits in experimental cerebral ischemia are now under intensive investigation (Van Reempts et al. , 1983 Alps et al. , 1988; Deshpande and Wie loch, 1986) . The effect of transient global cerebral ischemia induced by four-vessel occlusion upon the neuronal integrity of the striatum, neocortex, and hippocampus of the rat have been amply reported (Pulsinelli et al. , 1982) , but few authors have stud ied the effects of calcium antagonists in this model. The purpose of this paper therefore was to compare the effects of two calcium overload blockers (cin narizine and flunarizine) upon the neurological def icit, behavioral changes, and neuronal damage in-duced by transient forebrain ischemia and to look for a possible correlation between the ensuing func tional alterations and direct neuronal damage occur ring 72 h later.
Part of this work was presented as an oral com munication at the Second International Symposium on Pharmacology of Cerebral Ischaemia held III Marburg, F. R. G. , October 1988.
MATERIALS AND METHODS

Induction of reversible forebrain ischemia
Cerebral ischemia was produced by the four-vessel oc clusion technique (Pulsinelli and Brierley, 1979) . Male Wistar rats (Janvier) weighing 270-350 g were anesthe tized with halothane (2%) in a 3: 1, N20:02 gas mixture and the vertebral arteries electro cauterized at the first cervical vertebra. Four days later, both common carotid arteries were isolated under halothane anesthesia and atraumatic clips placed around each artery. Twenty-four hours later, the carotid clips were tightened for 15 min and then released in order to produce a transient cerebral ischemia. The loss of righting reflex during this period was used as a selection criteria and animals that con vulsed during the ischemia or during the reperfusion pe riods were excluded from the study.
Neurological deficit and behavioral studies
A neurological score (see Table 1 ) used to assess so matosensory functioning was measured 1, 3, 24, 48, and 72 h after ischemia, as described by Capdeville et al. (1986) . Locomotor activity was measured 24 and 48 h af ter the ischemia. The automatic motility apparatus con structed "in house" consisted of individual black boxes (40 x 40 x 10 cm) with a plexiglass roof. The enclosures were constantly scanned by infrared (IR) photodiodes in two dimensions and the amplified signals from these de- The total neurological score for a normal rat is 20.
tectors were recorded every 100 ms. The distance moved by an animal was computed every 15 min.
Histopathology
Seventy-two hours after ischemia, rats were anesthe tized with ether, the ascending aorta cannulated, and the brains perfused with heparinized saline (60 s) followed by 4% formaldehyde in a phosphate buffer. The brains were removed 1 h later and stored in the same fixative until they were embedded in paraffin for sectioning. Brain sec tions (10 /J-m) were stained with Luxol fast blue and cresyl violet and examined under a light microscope. Neuronal alterations were evaluated in three brain regions: the dor solateral part of the striatum, the neocortex, and the CAl region of the hippocampus, according to the method de scribed by Pulsinelli et al. (1982) . Morphological damage was graded using a scale of 0 to 3, with 0 representing normal tissue, 1 a few neurons damaged (,,;; 10%), 2 many neurons damaged (";; 50%), and 3 most neurons damaged (>50%). Each hemisphere was read and calculated inde pendently by the investigator under blind conditions.
Experimental protocol and drug administration
Four groups of animals were surgically prepared. Two sham-operated groups and two ischemic groups each re ceived vehicle or active drugs in suspension. Cinnarizine and flunarizine were suspended in 50% gum ara bic/distilled water, and given by oral administration (0.5 ml/100 g) at doses of 100 and 50 mg/kg, respectively, twice daily. The first treatment was given 1 h before the ischemic insult and the second 2 h after reperfusion. On the second, third, and fourth days, drugs were given early in the morning and late in the afternoon. The neurological score and locomotor activity were assessed 1 and 2 h, respectively, following treatment with vehicle or test drugs. Cinnarizine (base) and flunarizine (dihydrochlo ride) were purchased from Sigma Chemical Corp. (St. Louis, MO, U.S.A.).
Statistical analysis
Means and standard errors were calculated and com pared using the Mann-Whitney U test and Newman Keuls test for neurological score and locomotor activity, respectively. The X 2 test was used to compare the relative frequency distribution of all four stages of histological damage in each zone.
RESULTS
Neurological deficit
One hour after the ischemic episode, the neuro logical score was reduced by 54 and 40%, respec tively, in the two ischemic control groups for cinnarizine and flunarizine. At 3 and 24 h post ischemia, there was a gradual return of the neuro logical score towards normal values until, 24 and 72 h after the insult, normal neurological score val ues were obtained (see Fig. O .
Cinnarizine
Some animals died from convulsions 3 h after ischemia and were excluded from the study (1111 in the control ischemic group and 3/13 in the ischemic cinnarizine-treated group of rats). Cinnarizine sig-NEUROLOGICAL SCORE 20.
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. . nificantly reduced the effects of ischemia upon the neurological score at the 1 and 3 h time points fol lowing the insult but from 24 h onwards there was no statistically significant differences between the cinnarizine-treated and the ischemic control group (see Fig. 1 , top graph).
Flunarizine
No convulsions were observed in the ischemic control group, whereas one animal died from sei zure (1/15) and was excluded from the study in the flunarizine-treated group.
Flunarizine only significantly reduced the effects of ischemia on the neurological score at the 24 h time point, the other values at 1, 3, 48, and 72 h being not statistically significantly different from the ischemic control group of animals (see Fig. 1 , bottom graph). It could be argued, however, that the protective effects of flunarizine on the neuro logical score overall were quite similar to those pro duced by cinnarizine and that failure to observe an effect with the former drug at the 1 and 3 h time J Cereb Blood Flow Metab, Vol. 9, No.5, 1989 points may have been due to the less severe reduc tion in neurological score in the ischemic control group for flunarizine compared to that for cinnariz ine (see Fig. 1 ). However, additional experiments (data not shown) have demonstrated that there was still relatively little protection afforded by flunariz ine (in comparison to cinnarizine) in groups of rats having more marked neurological deficits than in the present series of experiments.
Locomotor activity
A temporary, global cerebral ischemia also in duced a latent hyperactivity in the animals, as as sessed by an increase in locomotor activity or run length, 24 and 48 h after the insult. In the ischemic control groups, there was no correlation between the intensity of this hyperactivity and the degree of neuronal damage measured at 72 h.
Cinnarizine
Treatment of animals with cinnarizine led to a reduction in run length from 93.5 ± 13.2 to 57. 8 ± 5. 0 mat 24 h postischemia in sham-operated groups but this value did not reach statistical significance. Similar results were seen 48 h after ischemia. At this dose, cinnarizine significantly reduced the hy peractivity seen in ischemic animals at the 24 and 48 h time points (Fig. 2, top graphs) . Indeed, the behavior pattern of the ischemic animals treated with cinnarizine was not significantly different from the sham-operated control group.
Flunarizine
In the sham-operated compared to the ischemic group of animals, 24 h after ischemia, the run length increased from 94.4 ± 12. 0 to 141. 9 ± 17. 6 m, which was less than that seen in ischemic animals in the cinnarizine study, where values of 210. 9 ± 26. 3 m were recorded. Slightly greater values in run length were seen 48 h after ischemia (97.6 ± 9.5 to 170. 1 ± 31. 5 m; see Fig. 2 , bottom graphs). Treat ment of animals with flunarizine elicited a signifi cant reduction in run length from 94. 4 ± 12. 0 to 26. 2 ± 5. 8 m in sham-operated animals. Therefore, al though flunarizine normalized the hyperactivity ob served in ischemic animals 24 and 48 h after the ischemia, it is not possible to discount a sedative like action of the drug in mediating this behavioral change.
Histopathology
In agreement with other published results (Pulsinelli and Brierley, 1979) , in this study, too, ischemia was found to induce qualitatively repro ducible histological damage in distinct brain areas 72 h after the ischemic episode (Fig. 3) . These re gions included the parietal and frontal cortex, the CAl region of the hippocampus, and the striatum. By comparing Tables 2 and 3 , it can be seen that, quantitatively, the degree of neuronal damage in the ischemic control group of animals does vary some what between different experiments. However, damage to the CAl region of the hippocampus was always the most severe, with the other regions, par ticularly the frontal cortex, being variably and much less severely affected.
Cinnarizine
Cinnarizine had little or no effect upon ischemia induced neuronal damage in the hippocampus, stri atum, and parietal cortex but did tend to reduce (non significantly) the minor damage observed in the frontal cortex (see Table 2 ).
Flunarizine
Flunarizine had marked protective effects in all four brain regions examined, completely preventing damage in the less ischemia-affected parietal and frontal cortex and striatum regions. However, the most striking effect of flunarizine was observed in the CAl region of the hippocampus, where even the severe grade 3 damage was reduced by almost 50% by this drug (see Table 3 ).
DISCUSSION
The present study has clearly confirmed previous reports that transient cerebral ischemia can induce a short-lived neurological deficit lasting up to 24-48 h, locomotor hyperactivity at 24 and 48 h, and histological evidence of selective neuronal damage 72 h postischemia (Pulsinelli and Brierley, 1979; Pulsinelli et aI. , 1982; Van Reempts et aI. , 1983; Donzanti and Uretsky, 1984; Simon et aI. , 1984; Chandler et aI. , 1985; Deshpande and Wieloch, 1986; Van Reempts et aI. , 1986; Alps et aI. , 1988) . In these experiments, using the four-vessel occlu sion model in the rat, there was no obvious rela tionship between the neurological score and the de gree of neuronal damage observed even after drug treatment. Therefore, despite the permanent neuro nal damage in the striatum, hippocampus, and neo cortex of these animals, the neurological score re turns to normal values in rats subjected to transient cerebral ischemia. This suggests that these acute effects of ischemia might be due to hemodynamic or metabolic perturbations that rapidly return to con trol values following restoration of flow (Marie, 1986) . With regard to the superiority of cinnarizine over flunarizine in ameliorating changes in this pa rameter, it should be reiterated that the greater neu rological deficit observed in the cinnarizine control group does not appear to be responsible for this A c drug appearing to be significantly more active than flunarizine at the early postischemia time points. It could be that sedative effects, due to HI-histamine antagonist effects of these drugs, could interfere with the measurement of neurological deficit score and that this effect is more marked with flunarizine because of its much longer duration of action (Van den Akker, 1986). In conclusion, we observed no relationship between the neurological score in con trol and treated animals and the extent of ischemia induced neuronal damage at the 72 h time point.
It is well documented that after ischemia, some cells are rapidly destroyed within 24 h, whereas others require several days before histological evi dence of death becomes apparent. The delayed neu ronal death in the CAl region of the hippocampus of the rat is an example of the latter case (Van Re empts et aI. , 1983) . In this respect, therefore, as far as behavioral correlates for neuronal death are con cerned, the delayed hyperactivity observed under our experimental conditions may better reflect neu ronal damage in the CAl region than the neurolog ical deficit, which is only evident immediately after the ischemic event. Indeed, in the gerbil model, fol lowing bilateral carotid artery occlusion, it has now been reported that the hyperactivity is closely cor-J Cereb Blood Flow Metab, Vol. 9, No. 5, 1989
FIG. 3. Effect of flunarizine on histopathological changes in the rat before and after 15 min of global cerebral ischemia. A: coronal section of the dorsal hippocampus in a sham operated, control rat. Note that the CA1 pyramidal cell layer (between arrows) is well-stained as are the other CA regions (magnification: x15) . Inset: all CA1 neurons are well pre served (x220). B: coronal section of the dorsal hippocampus in an ischemic control rat. Almost all pyramidal cells of the CA1 region (between arrows) are less receptive to staining. Inset: ischemic neurons are characterized by a retraction of the cell body (arrow head) with eosinophilia of the cyto plasm. A retraction of the cell with hyperchromasia of the nucleus (arrows) is also observed. Most CA1 neurons have degenerated and disappeared and are replaced by glial cells. C: coronal section of the dorsal hippocampus in a flunariz ine-treated rat. The CA1 region (between arrows) is receptive to staining, in a similar way to sham-operated, control rats. Inset: Most CA 1 neurons are preserved in the high power section.
related with the extent of the neuronal damage (Ru dolphi et aI. , 1988; Gerhardt and Boast, 1988) . In these studies using the rat, however, there was no correlation between the intensity of the hyperactiv ity and the final degree of neuronal damage, as as sessed histologically in control ischemic groups of animals. Cinnarizine treatment completely inhibited the locomotor hyperactivity at the 24 and 48 h time points, whereas flunarizine, although completely abolishing this postischemic effect, also reduced lo comotor activity in the sham-operated group of rats. Thus, it was not possible to conclude if this was a real protection against the behavioral changes of ischemia induced by flunarizine or whether it was due to a sedative-like effect of the drug. As dis cussed previously, it has been reported that cin narizine and flunarizine possess Hchistamine an tagonist properties that, following penetration into the central nervous system (CNS), may endow these molecules with sedative properties (A wouters et aI. , 1975; Van Nueten and Janssen, 1973) . Given that flunarizine is a much longer-acting drug than cinnarizine (Van den Akker, 1986), it could be that a sedative effect is also interfering with these indi rect measurements of neuronal function, particu larly in the case of flunarizine. All rats were subjected to 15 min of four-vessel occlusion fol lowed by 72 h of recirculation. Cinnarizine (100 mg/kg) was given orally I h before ischemia and then twice daily for 3 days. Re sults are the mean values obtained from at least eight animals in sham-operated control (Sham control), ischemic control (Isch. control), and in ischemic animals treated with cinnarizine (Isch. cinn). a p < 0.05, b p < 0.01, c p < 0.001 between sham-operated control and ischemic control groups (X2 test).
d Not significant between ischemic control and ischemic cin narizine groups (X2 test).
Although it must be concluded that the results obtained on the behavioral parameters are difficult to interpret and, in the rat under present conditions, are very poorly correlated with the amount of en suing neuronal damage, there was clear-cut evi dence for a neuronal protective effect. With cin narizine, this manifested itself as a slight, nonsig nificant effect and then only upon the less severe neuronal damage observed in the frontal cortex but with flunarizine protection was apparent even in the severely damaged CAl zone of the hippocampus. The results concerning neuronal protection with flu narizine confirm several studies in other models of cerebral ischemia. Thus, flunarizine has been shown to protect against cortical damage in the Levine rat model (Van Reempts et aI. , 1983) , to protect the CAl hippocampal region in rats submit ted to temporary carotid occlusion plus hypoten sion (Deshpande and Wieloch, 1986) , and to protect gerbils subjected to transient cerebral ischemia by bilateral carotid occlusion (Alps et aI., 1988) .
Turning now to the possible mechanism respon sible for this protective effect of flunarizine and cin narizine upon certain neuronal cell types in the eNS, it has been suggested that selectively vulner able neurons are those in which calcium entry is All rats were subjected to 15 min of four-vessel occlusion fol lowed by 72 h of recirculation. Flunarizine (50 mg/kg) was given orally I h before ischemia and then twice daily for 3 days. Re sults are the mean values obtained from at least 10 animals in sham-operated (Sham control), ischemic control (Isch. control), and in ischemic animals treated with flunarizine (Isch. flun). a p < 0.05, b p < 0.01, c p < 0.001 between sham-operated control and ischemic control groups (X2 test).
d p < 0.05, e p < 0.01 between ischemic control and ischemic flunarizine groups (X2 test).
favored by cell depolarization and spiking behavior (Meldrum, 1983) . Furthermore, evidence suggests that calcium is translocated from extra-to intracel lular sites during ischemia but why the damage is tardive is still not clear (see Siesj6, 1988) . It is well known that flunarizine and cinnarizine possess rel atively potent "calcium antagonist" effects, espe cially upon cerebral vascular smooth muscle (Anderson et aI., 1986) . Theoretically, calcium an tagonists could have two major sites of action within the CNS, upon vascular smooth muscle, or upon the neuronal elements.
Potential vascular effects
Recently, Spedding (1986) has classified calcium antagonists into three subgroups using functional pharmacological criteria: group I, the dihydro pyridines (DHPs) such as nifedipine and nimo dipine; group II, verapamil and diltiazem; and group III, the diphenylalkylamines in which cin narizine and flunarizine are to be found. The group I calcium antagonist (nimodipine) at therapeutic doses has relatively selective effects upon voltage operated channels (VOCs) in the sarcolemma of vascular smooth muscle. Nimodipine has been shown selectively to increase cerebral blood flow (CBF) and reduce the postischemic hypoperfusion, which, it has been suggested, may be an important factor contributing to the ensuing neurological def icit (Siesj6, 1981; Hossmann, 1982; White et aI. , 1982) . Improvement of this hypoperfusion episode by nimodipine may thus have a beneficial effect upon neuronal recovery from a transient ischemic insult (Steen et aI. , 1983; White et aI. , 1983) . How ever, nimodipine has recently been shown to be in active against ischemia-induced neuronal damage (Alps et aI. , 1988; Vibulsresth et aI. , 1987) . There fore, a simple effect upon VOCs in vascular smooth muscle would seem not to be the sole mechanism involved in the protective effects observed with cin narizine and especially flunarizine in this model. As stated previously, cinnarizine and flunarizine be long to the group III calcium antagonists and, al though both compounds appear to inhibit VOCs, they also have additional sites of action inside the cell (Bou et aI. , 1983) , perhaps upon calmodulin (Lugnier et aI. , 1984) , and have been termed cal cium overload blockers to differentiate them from the other subgroups of calcium antagonists that ap pear to act more or less selectively at VOCs at ther apeutic doses (Van Zwieten, 1986) . In vitro and in vivo studies have shown that flunarizine is a more potent and longer-acting calcium antagonist than cinnarizine (Kavasawa et aI. , 1982) , which could also explain the greater degree of neuronal protec tion observed with the former drug in these studies.
Potential neuronal effects
Three types of voltage-operated calcium channels have been described in mammalian neuronal plas malemma, i. e., T-, L-, and N-type channels (Tsien et aI. , 1988; Miller, 1987) . Recent evidence suggests that, presynaptically, N channels are mainly in volved in transmitter release although "distant" L channels may also be activated during strong depo larizations (Miller, 1987) . Postsynaptically, T and L VOCs may be present together with certain types of receptor-operated channels (ROCs). The group I DHP calcium antagonists block, relatively selec tively, the L channel whereas recently flunarizine has been found to have additional effects upon the T channel in cardiac muscle (Tytgat et aI. , 1988 ), which appears to influence SA-node pacemaker ac tivity (Reuter and Porzig, 1988) . Although the role of the T channel in neurons is not known, it is in teresting to speculate whether an effect on the pre potential in spontaneously active cells might be re sponsible for the greater neuroprotective activity of flunarizine compared to calcium antagonists in groups I and II. With respect to possible presynap tic actions of calcium antagonists, it has been pro posed that in gerbils and rats during global isch-J Cereb Blood Flow Metab, Vol. 9, No.5, 1989 emia, there is a release of excitatory amino acid (EAA) neurotransmitters such as glutamate and as partate (Wieloch, 1985; Rothman and Olney, 1986; Grotta et aI. , 1988) . Theoretically, calcium antago nists could reduce EAA release by inhibition of cal cium influx at the presynaptic level since transmit ter release is a calcium-dependent process. How ever, as discussed previously, this influx is mainly via N-type calcium channels, which are unaffected by presently known organic calcium antagonists (Miller, 1987) . Nevertheless, in this regard, evi dence is equivocal; nifedipine, verapamil, and flu narizine have been shown not to inhibit presynaptic calcium influx in the rat hippocampus (Louvel et aI. , 1986; Jones and Heinemann, 1987) , but in cere bral cortex synaptosomes, calcium uptake stimu lated by depolarization has been reported to be in hibited by cinnarizine and flunarizine (Wibo et aI. , 1983) .
Calcium antagonists may also oppose calcium in flux following depolarization of the postsynaptic neuronal cell membrane by, for example, EAAs. At the postsynaptic level, while many DHP-binding sites are present on nerve cells, there is no close correlation between binding density and the vulner ability of the neurons to ischemia (Siesj6, 1988) . Thus, calcium ions must gain access to the nerve cell cytoplasm via other routes, in addition to the VOCs. It is known that stimulation of N methyl-D-aspartate (NMDA) receptors by gluta mate induces an influx of calcium ions in postsyn aptic neurons through stimulation of ROCs. A stim ulation of ROCs may also elicit calcium release from intracellular stores, which then contributes to wards calcium overload and cell death (Auyeung et al. , 1986) . NMDA antagonists such as D aminoadipate have been shown to reduce ischemia induced locomotor activity in the rat (Donzanti and Uretsky, 1984) . However, another NMDA antago nist, MK 801 (Kemp et aI. , 1986) , did not prevent the neuronal damage subsequent to ischemia in the four-vessel occlusion model in the rat (Poignet, Beaughard, Lecoin, and Massingham, in prepara tion) . Furthermore, it should be pointed out that at the dose used (5 mg/kg intraperitoneal), MK 801 induced marked sedative effects in these animals. Thus, sedation is not irrevocably linked to neuronal protection and indicates that an effect other than sedation may be responsible for the neuronal pro tection observed with flunarizine in these experi ments. Finally, an intracellular effect of flunarizine upon neuronal calcium ion translocations, as de scribed previously for vascular smooth muscle, may account for the effectiveness of this compound in these experiments and explain why protection is not seen with calcium antagonists of the DHP type, which act only at the level of L-type VOCs.
In conclusion, this study has clearly shown that in the four-vessel occlusion model in the rat, fol lowing treatment with cinnarizine and flunarizine, there is no relationship between ischemia-induced neurological deficit, locomotor hyperactivity, and the degree of ensuing neuronal damage. While their site and mechanism of action is at present not clear and may involve effects upon more than one type of VOC, or intracellular effects at vascular and neuro nal cell levels, it appears that group III calcium an tagonists (Spedding, 1986) can improve postisch emic neuronal survival after a transient cerebral ischemia. More selective group III compounds, lacking sedative activity, for example, may provide the answer to an important clinical need, i.e., main tenance of neuronal integrity following a transient cerebral ischemic attack.
